SCHEMBL19086066

SCHEMBL19086066

C=NC(=N)Nc1cc([N+](=O)[O-])c(F)cc1OC

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.39
PKM P14618 3/20 0.39
HTT P42858 1/20 0.39
MEN1 O00255 5/20 0.38
RAB9A P51151 1/20 0.38
MAPT P10636 4/20 0.38
ALDH1A1 P00352 3/20 0.38
GAA P10253 2/20 0.38
POLB P06746 2/20 0.38
LMNA P02545 2/20 0.38
ATM Q13315 1/20 0.38
ABCB1 P08183 4/20 0.38
ABCC1 P33527 4/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
KDM4E B2RXH2 2/20 0.37
MAPK1 P28482 1/20 0.36
ALOX12 P18054 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27020103 0.87 ALDH1A1 (0.41) KMT2APKMHTTMEN1RAB9A
SCHEMBL18038909 0.81 ALDH1A1 (0.49) KMT2APKMHTTMEN1RAB9A
SCHEMBL20680892 0.81 PKM (0.45) KMT2APKMHTTMEN1RAB9A
SCHEMBL19254677 0.79 ABCC1 (0.39) KMT2APKMHTTMEN1RAB9A
SCHEMBL19239593 0.78 ALDH1A1 (0.42) KMT2APKMHTTMEN1RAB9A
SCHEMBL17059202 0.76 PKM (0.46) KMT2APKMHTTMEN1RAB9A
SCHEMBL29823126 0.76 PKM (0.46) KMT2APKMHTTMEN1RAB9A
SCHEMBL29025170 0.74 MAPK1 (0.41) KMT2APKMHTTMEN1RAB9A
SCHEMBL30063515 0.74 MAPT (0.45) KMT2APKMHTTMEN1RAB9A
SCHEMBL17683328 0.74 MAPT (0.45) KMT2APKMHTTMEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017117070-A1 DEUTERATED COMPOUNDS FOR TREATING CANCER AND RELATED DISEASES AND CONDITIONS, AND COMPOSITIONS AND METHODS THEREOF NeuForm Pharmaceuticals, Inc. (US) 2017-07-06 WO disclosed